A Review: Propolis As An Antiinflammatory Adjunct Therapy in Chronic Kidney Disease

Elpiani Depari; Ririe Fachrina Malisie

doi:10.35451/jfm.v7i2.2613

Authors

Elpiani Depari Program Studi Magister Ilmu Biomedik Fakultas Kedokteran Universitas Sumatera Utara
Ririe Fachrina Malisie Program Studi Magister Ilmu Biomedik Fakultas Kedokteran Universitas Sumatera Utara

DOI:

https://doi.org/10.35451/jfm.v7i2.2613

Keywords:

chronic kidney disease, inflammation, propolis, cytokine, Anti-inflammatory

Abstract

Chronic Kidney Disease (CKD) is a disease with abnormalities of the structure and function of kidney that last for at least 3 months and has an impact on health. Inflammation is a progression factor and outcome of CKD. Diabetes, hypertension, cardiovascular disease, exposure to environmental pollution and use of nephrotoxic drugs develop into CKD through inflammation. Inflammation in CKD caused complications in cardiovascular disease, bone mineral disorders, anemia and immune disorders, as well as reducing the patient's quality of life. Cardiovascular complications are the main cause of CKD patients’ death. Renal replacement therapy such as hemodialysis is not effective enough to overcome the inflammation, because unable to remove intermediate molecules and protein-bound molecules, the majority of which are inflammatory markers such as cytokines, namely TNF-?, IL-1, IL-6 and others. Propolis, a natural bee resin product, has anti-inflammatory effects, because it contains many bioactive phytochemicals such as flavonoids, phenolic acids, esters, diterpenes, aromatic aldehydes, amino acids, fatty acids, vitamins and minerals. It inhibits the production and release of cytokines through inhibiting NF-kB (nuclear factor kappa Beta) activity, reducing COX-2 expression and inhibiting nitric oxide (NO). Many clinical trials of propolis in CKD have been carried out and reported safe and beneficial, including in patients undergoing dialysis. Propolis has been proven able to reduce several inflammatory markers, such as TNF-?, interleukin and others. It has great potential as a safe additional therapy in CKD patients, both dialysis and non-dialysis.

Downloads

Download data is not yet available.

References

National Kidney Foundation. Global Facts: About Kidney Disease 2024. https://www.kidney.org/global-facts-about-kidney-disease (accessed December 1, 2024).

World Kidney Day. Kidney Health for All 2024. https://www.worldkidneyday.org/2024-campaign/.

Kovesdy CP. Epidemiology of Chronic Kidney Disease: An Update 2022. Kidney Int Suppl 2022;12:7–11.

Europian Parliament. A systematic EU approach to chronic kidney disease. Eur Parliam 2022. https://www.europarl.europa.eu/doceo/document/O-9-2022-000006_EN.html (accessed December 1, 2024).

Himmelfarb J, Ikizler TA. Chronic kidney disease, dialysis, and transplantation. Fourth Edi. Philadelpia: Elsevier; 2019.

Podkowi?ska A, Formanowicz D. Chronic kidney disease as oxidative stress-and inflammatory-mediated cardiovascular disease. Antioxidants 2020;9:1–54. https://doi.org/10.3390/antiox9080752.

KDIGO. Clinical Practice Guideline for The Evaluation and Management of Chronic Kidney Disease. vol. 105. 2024.

Daugirdas JT. Handbook of dialysis therapy. fifth. Philadepia: Wolters Kluwer Health; 2015.

Zakerkish M, Jenabi M, Zaeemzadeh N, Hemmati AA, Neisi N. The Effect of Iranian Propolis on Glucose Metabolism, Lipid Profile, Insulin Resistance, Renal Function and Inflammatory Biomarkers in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blind Clinical Trial. Sci Rep 2019;9:1–11. https://doi.org/10.1038/s41598-019-43838-8.

Petreski T, Piko N, Ekart R, Hojs R, Bevc S. Review on inflammation markers in chronic kidney disease. Biomedicines 2021;9:1–16. https://doi.org/10.3390/biomedicines9020182.

PERNEFRI. 13th Annual Report of Indonesian Renal Registry 2020. Indones Ren Regist 2020;13:11.

Yang J. Efficacy of medium cut?off dialyzers and comparison with high?flux dialyzers in patients on.pdf 2021.

Rapa SF, Di Iorio BR, Campiglia P, Heidland A, Marzocco S. Inflammation and oxidative stress in chronic kidney disease—potential therapeutic role of minerals, vitamins and plant-derived metabolites. Int J Mol Sci 2020;21. https://doi.org/10.3390/ijms21010263.

Baptista BG, Fanton S, Ribeiro M, Cardozo LF, Regis B, Alvarenga L, et al. The effect of Brazilian Green Propolis extract on inflammation in patients with chronic kidney disease on peritoneal dialysis: A randomised double-blind controlled clinical trial. Phytomedicine 2023;114:12–3.

Chermut TR, Fonseca L, Figueiredo N, de Oliveira Leal V, Borges NA, Cardozo LF, et al. Effects of Propolis on Inflammation Markers in Patients Undergoing Hemodialysis: A Randomized, Double-Blind Controlled Clinical Trial. Complement Ther Clin Pract 2023;51:12–4.

Silveira MA, Malta-Santos H, Rebouças-Silva J, Teles F, Batista Dos Santos Galvão E, Pinto De Souza S, et al. Effects of Standardized Brazilian Green Propolis Extract (EPP-AF®) on Inflammation in Haemodialysis Patients: A Clinical Trial. Int J Nephrol 2022. https://doi.org/10.1155/2022/1035475.

Zulhendri F, Lesmana R, Tandean S, Christoper A, Chandrasekaran K, Irsyam I, et al. Recent Update on the Anti-Inflammatory Activities of Propolis. Molecules 2022;27:1–61. https://doi.org/10.3390/molecules27238473.

Chavda VP, Chaudhari AZ, Teli D, Balar P, Vora L. Propolis and Their Active Constituents for Chronic Diseases. Biomedicines 2023;11:1–24. https://doi.org/10.3390/biomedicines11020259.

Hossain R, Quispe C, Khan RA, Saikat ASM, Ray P, Ongalbek D, et al. Propolis: An update on its chemistry and pharmacological applications. Chinese Med (United Kingdom) 2022;17. https://doi.org/10.1186/s13020-022-00651-2.

Rosner MH, Reis T, Husain-Syed F, Vanholder R, Hutchison C, Stenvinkel P, et al. Classification of Uremic Toxins and Their Role in Kidney Failure. Clin J Am Soc Nephrol 2021;16:1918–28. https://doi.org/10.2215/CJN.02660221.

Stone WL, Basit H, Zubair M, Burns B. Phatology, Inflammation. StatPearls; 2024.

Harahap HY, Syarifuddin S, Arum C, Cahya D, Kristina S, Sinaga B. Uji Efektivitas Antiinflamasi Sediaan Gel Ekstrak Etanol Umbi Bawang Sabrang ( Eleutherine bulbosa ) terhadap Luka Sayatan pada Tikus Wistar Test of the Anti-Inflammatory Effectiveness of Ethanol Extract Gel Preparation of Sabrang Onion Bulb ( Eleutherine. J Farm 2024;7:61–7. https://doi.org/10.35451/jfm.v7i1.2317.

Purba N, Lubis KP. Uji Aktivitas Antiinflamasi Ekstrak Daun Keji Beling ( Strobilanthes crispa ( L .) Blume ) Terhadap Mencit Putih Jantan ( Mus musculus ) Antiinflamation Activity Test of Keji Beling ( Strobilanthes crispa ( L .) Blume ) Leaves Extraction on White Mencites. J Farm 2024;7:118–25. https://doi.org/10.35451/jfm.v7i1.2340.

Gusev E, Zhuravleva Y. Inflammation: A New Look at an Old Problem. Int J Mol Sci 2022;23:1–41. https://doi.org/10.3390/ijms23094596.

Rajendran P, Chen YF, Chen YF, Chung LC, Tamilselvi S, Shen CY, et al. The multifaceted link between inflammation and human diseases. vol. 233. 2018. https://doi.org/10.1002/jcp.26479.

Dheda S, Vesey DA, Hawley C, Johnson DW, Fahim M. Effect of a Hemodialysis Session on Markers of Inflammation and Endotoxin. Int J Inflam 2022;2022. https://doi.org/10.1155/2022/8632245.

Thaha M. The role of inflammation in chronic Kidney Disease. Indones J Kidney Hypertens 2019;II:4–13. https://doi.org/10.1111/j.1755-3768.2014.483.x.

Liu C, Chu D, Kalantar-Zadeh K, George J, Young HA, Liu G. Advanced Science - 2021 - Liu - Cytokines From Clinical Significance to Quantification.pdf. Adv Sci 2021;2004433:1–29.

Kleiner G, Marcuzzi A, Zanin V, Monasta L, Zauli G. Cytokine levels in the serum of healthy subjects. Mediators Inflamm 2013;2013. https://doi.org/10.1155/2013/434010.

Dimitrova D, Youroukova V, Ivanova-Todorova E, Tumangelova-Yuzeir K, Velikova T. Serum levels of IL-5, IL-6, IL-8, IL-13 and IL-17A in pre-defined groups of adult patients with moderate and severe bronchial asthma. Respir Med 2019;154:144–54. https://doi.org/10.1016/j.rmed.2019.06.024.

Kuribayashi T. Elimination half-lives of interleukin-6 and cytokine-induced neutrophil chemoattractant-1 synthesized in response to inflammatory stimulation in rats. Lab Anim Res 2018;34:80–3. https://doi.org/10.5625/lar.2018.34.2.80.

Yang G, Shao GF. Elevated serum IL-11, TNF ?, and VEGF expressions contribute to the pathophysiology of hypertensive intracerebral hemorrhage (HICH). Neurol Sci 2016;37:1253–9. https://doi.org/10.1007/s10072-016-2576-z.

Liu Q, Xia Z, Huang T, Yang F, Wang X, Yang F. Establishment of reference intervals for plasma IL-2, IL-4, IL-5, and IL-17A in healthy adults from the Jiangsu region of eastern China using flow cytometry: A single-center study. Cytokine 2024;179:156594. https://doi.org/10.1016/j.cyto.2024.156594.

Wang X, Wong K, Ouyang W, Rutz S. Targeting IL-10 family cytokines for the treatment of human diseases. Cold Spring Harb Perspect Biol 2019;11. https://doi.org/10.1101/cshperspect.a028548.

Zulhendri F, Ravalia M, Kripal K, Chandrasekaran K, Fearnley J, Perera CO. Propolis in metabolic syndrome and its associated chronic diseases: A narrative review. Antioxidants 2021;10:1–20. https://doi.org/10.3390/antiox10030348.

Bhargava P, Mahanta D, Kaul A, Ishida Y, Terao K, Wadhwa R, et al. Experimental evidence for therapeutic potentials of propolis. Nutrients 2021;13:1–23. https://doi.org/10.3390/nu13082528.

Tandean S, Japardi I, Rusda M, Indharty RS, Lelo A, Aman RA, et al. Chemical Composition and Neuroprotective Properties of Indonesian Stingless Bee (Geniotrigona thoracica) Propolis Extract in an In-Vivo Model of Intracerebral Hemorrhage (ICH). Nutrients 2024;16:1–19. https://doi.org/10.3390/nu16121880.

Santos LM, Fonseca MS, Sokolonski AR, Deegan KR, Araújo RPC, Umsza-Guez MA, et al. Propolis: types, composition, biological activities, and veterinary product patent prospecting. J Sci Food Agric 2020;100:1369–82. https://doi.org/10.1002/jsfa.10024.

Pranata C, Darmirani Y, Limbing R. Uji Efektivitas Antiinfllamasi Ekstrak Etanol Daun Kumis Kucing ( Orthisiphon aristatus ) Terhadap Udema Kaki Mencit Jantan ( Mus musculus ) Test of the Anti-Inflammatory Effectiveness of Ethanol Extract of Cat ’ s Whiskers Leaves ( Orthisiphon Aristatus 2024:41–7.

Salami F, Mohebbati R, Hosseinian S, Shahraki S, Hossienzadeh H, Rad AK. Propolis and its therapeutic effects on renal diseases, a review. Iran J Basic Med Sci 2023;27:2–8. https://doi.org/10.22038/IJBMS.2024.73081.15880.

Ranneh Y, Akim AM, Hamid HA, Khazaai H, Fadel A, Mahmoud AM. Stingless bee honey protects against lipopolysaccharide induced-chronic subclinical systemic inflammation and oxidative stress by modulating Nrf2, NF-?B and p38 MAPK. Nutr Metab 2019;16:1–17. https://doi.org/10.1186/s12986-019-0341-z.

Teles F, Da Silva TM, Da Cruz FP, Honorato VH, De Oliveira Costa H, Barbosa APF, et al. Brazilian red propolis attenuates hypertension and renal damage in 5/6 renal ablation model. PLoS One 2015;10:1–15. https://doi.org/10.1371/journal.pone.0116535.

Anvarifard P, Ostadrahimi A, Ardalan M, Anbari M, Ghoreishi Z. The effects of propolis on pro-oxidant–antioxidant balance, glycemic control, and quality of life in chronic kidney disease: a randomized, double-blind, placebo-controlled trial. Sci Rep 2023;13:1–11. https://doi.org/10.1038/s41598-023-37033-z.

Silveira MAD, Malta-Santos, Hayna, ReboucasTeles F, Berretta AA, Sanches TR, Rodrigues CE, Seguro AC, et al. Effects of Brazilian green propolis on proteinuria and renal function in patients with chronic kidney disease: A randomized, double-blind, placebo-controlled trial. BMC Nephrol 2019;20:1–12. https://doi.org/10.1186/s12882-019-1337-7.